| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670147 Compositions containing cultured mitotic human stem cells |
| 09/23/1997 | US5670134 Method for evaluating and modifying biological activity |
| 09/23/1997 | CA1339468C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| 09/22/1997 | CA2200421A1 Processes for preparing acarviosyl transferase and for using it in the conversion of acarbose homologues into acarbose for the preparation of a carbose homologues |
| 09/18/1997 | WO1997034146A1 Inhibiting protein interactions |
| 09/18/1997 | WO1997034143A1 Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034007A1 Promoter |
| 09/18/1997 | WO1997034006A1 Plasmid |
| 09/18/1997 | WO1997034005A1 Alkaline cellulase and method of producing same |
| 09/18/1997 | WO1997034004A1 β-FRUCTOFURANOSIDASE AND ITS GENE, METHOD OF ISOLATING β-FRUCTOFURANOSIDASE GENE, SYSTEM FOR PRODUCING β-FRUCTOFURANOSIDASE, AND β-FRUCTOFURANOSIDASE VARIANT |
| 09/18/1997 | WO1997034003A1 Process of raising squalene levels in plants and dna sequences used therefor |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997034000A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033997A1 Method of treating muscular disorders |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033994A1 Use of viral cis-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
| 09/18/1997 | WO1997033993A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | WO1997033992A1 Selected oligonucleotides with anti-cytomegalovirus activity |
| 09/18/1997 | WO1997033991A1 Short external guide sequences |
| 09/18/1997 | WO1997033989A1 TRANSGENIC ANIMALS HAVING A DISRUPTED eNOS GENE AND USE THEREOF |
| 09/18/1997 | WO1997033988A1 Double mutants of dihydrofolate reductase and methods of using same |
| 09/18/1997 | WO1997033986A1 Arginase ii |
| 09/18/1997 | WO1997033985A1 Arginase ii |
| 09/18/1997 | WO1997033984A1 Novel achromobacter lyticus protease variants |
| 09/18/1997 | WO1997033982A1 Protein having cellulase activities and process for producing the same |
| 09/18/1997 | WO1997033980A1 Transgenic animals having a disrupted endothelial nitric oxide synthase gene and methods of use |
| 09/18/1997 | WO1997033979A1 Transgenic model of hepatitis c virus infection |
| 09/18/1997 | WO1997033976A1 Ds11 (kctc 0231bp), novel bacillus sp. strain and novel phytase produced by it |
| 09/18/1997 | WO1997033974A2 Dna encoding alpha-1(1,4)-glucan acetyl-transferase |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033895A1 Isolated rna molecules which bind to arginine and uses thereof |
| 09/18/1997 | WO1997033623A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 09/18/1997 | WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 09/18/1997 | WO1997033610A1 DNA ENCODING 28 kDa GLUTATHIONE S-TRANSFERASE OF SCHISTOSOMA MANSONI AND USES THEREOF |
| 09/18/1997 | WO1997033607A1 Orally-administered interferon-tau compositions and methods |
| 09/18/1997 | WO1997033550A2 Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression |
| 09/18/1997 | WO1997033474A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | WO1997033466A1 Non-genetically modified mammal as a model for multiple sclerosis |
| 09/18/1997 | WO1997025440A3 Methods and compositions for diagnosis of hyperhomocysteinemia |
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | WO1997007815A3 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/18/1997 | DE19610972A1 Production of stress-tolerant organisms |
| 09/18/1997 | DE19608813A1 Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen Conjugate for influencing protein-protein interactions |
| 09/18/1997 | CA2407668A1 Human bikunin |
| 09/18/1997 | CA2249182A1 Death domain containing receptors |
| 09/18/1997 | CA2248998A1 Inhibiting protein interactions |
| 09/18/1997 | CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | CA2248932A1 Oligonucleotides targeted to angiotensinogen mrna |
| 09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
| 09/18/1997 | CA2248707A1 Clostridium perfringens vaccines |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248612A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248547A1 Process of raising squalene levels in plants and dna sequences used therefor |
| 09/18/1997 | CA2248541A1 Mouse tec tyrosine kinase promoter |
| 09/18/1997 | CA2248540A1 Dna encoding alpha-1(1,4)-glucan acetyl-transferase |
| 09/18/1997 | CA2248539A1 Use of viral cis-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites |
| 09/18/1997 | CA2248538A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | CA2248355A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | CA2248158A1 Targeted site specific drug delivery compositions and method of use |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2247805A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
| 09/18/1997 | CA2246622A1 Alkaline cellulase and method of producing same |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/18/1997 | CA2221028A1 Non-genetically modified mammal as a model for multiple sclerosis |
| 09/17/1997 | EP0795751A2 Whole blood sample preparation for polymerase chain reaction using ammonium chloride and a carboxylic acid or metal carboxylate for selective red blood cell lysis |
| 09/17/1997 | EP0795612A2 Amplifying and detecting target nucleic acids using a post amplification incubation step |
| 09/17/1997 | EP0795611A1 Amplification and detection of mycobacterium avium complex species |
| 09/17/1997 | EP0795606A1 Process for producing transformed cell |
| 09/17/1997 | EP0795605A1 Denatured low-density lipoprotein receptor |
| 09/17/1997 | EP0795602A2 Method to access nucleic acids from cells |
| 09/17/1997 | EP0795325A1 Plasmid entrapping multilamellar liposomes |
| 09/17/1997 | EP0795033A2 Discontinuous probe design using hybritope mapping |
| 09/17/1997 | EP0795032A2 Methods of immobilizing oligonucleotides to solid support materials and methods of using support bound oligonucleotides |
| 09/17/1997 | EP0795030A1 Method for making recombinant yeast artificial chromosomes |
| 09/17/1997 | EP0795026A1 Novel ribozymes and novel ribozyme selection systems |
| 09/17/1997 | EP0795021A2 Retroviral delivery of full length factor viii |
| 09/17/1997 | EP0795020A1 Plant stearoyl-acp thioesterase sequences and methods to increase stearate content in plant seed oils |
| 09/17/1997 | EP0795019A2 Genetic transformation using a parp inhibitor |
| 09/17/1997 | EP0795018A1 Dna sequences encoding carbohydrate polymer synthesizing enzymes and method for producing transgenic plants |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0795016A1 Vs ribozymes |
| 09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
| 09/17/1997 | EP0795014A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 09/17/1997 | EP0795013A1 Receptor for cell-binding domain of thrombospondins |